Why is Hemo Organic falling/rising?

As of 09-Jul, Hemo Organic Ltd's stock price is currently at 10.00, reflecting an increase of 0.39 or 4.06%. The stock has shown a positive performance today, outperforming its sector by 4.02% and has gained consecutively over the last two days, resulting in a total return of 4.17% during this period. However, despite this recent uptick, the stock is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a longer-term downward trend. Additionally, there has been a significant decline in investor participation, with delivery volume dropping by 92.05% compared to the 5-day average. The company has a negative book value and a weak long-term fundamental strength, characterized by high debt levels and consistent underperformance against benchmarks over the past three years.
In the broader market context, Hemo Organic's recent performance contrasts sharply with the benchmark, as it has experienced a -6.45% return over the past week while the Sensex has increased by 0.15%. This underperformance is further highlighted by the stock's year-to-date decline of 19.74%, compared to the Sensex's gain of 6.91%. Despite the recent positive results in March, including the highest quarterly profit figures, the overall outlook remains cautious due to the company's negative EBITDA and poor long-term growth prospects. The combination of these factors suggests that while there may be short-term gains, the stock's long-term viability remains questionable, contributing to its overall weak performance in the market.